🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to evaluate the immunogenicity, safety and reac...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-06-15
Trial ID
NCT01147900
Treatments Being Tested
This is a study to evaluate the immune response and safety of GSK Biologica...
Status
Completed
Location
GSK Investigational Site
Start Date
2003-11-11
Trial ID
NCT00197236
This protocol posting deals with objectives \& outcome measures of an exten...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-05-14
Trial ID
NCT00891176
An open clinical trial to study the immune response and safety after giving...
Status
Completed
Location
Norwegian Institute of Public Health
Start Date
2007-04
Trial ID
NCT00514059
Treatments Being Tested
This study will evaluate the safety and immune response of the Novartis Men...
Status
Completed
Location
Growing Up Pediatrics
Start Date
2007-03
Trial ID
NCT00474526
The purpose of this booster study is to evaluate, in subjects primed in the...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-02-01
Trial ID
NCT00627458
Treatments Being Tested
The aim of the current study is to determine whether ibuprofen, given as im...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-11-12
Trial ID
NCT01235949
Treatments Being Tested
Assess immuno, reacto of the 10-valent pneumococcal vaccine after 2 doses (...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-01-01
Trial ID
NCT00307034
Treatments Being Tested
The purpose of this study is to assess reactogenicity and safety of simulta...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-12-03
Trial ID
NCT01094171
Treatments Being Tested
This study will assess the efficacy, safety, and immunogenicity of a 3-dose...
Status
Completed
Location
Multiple Locations
Start Date
2014-05-30
Trial ID
NCT02062385
Treatments Being Tested